Sosei Group Corporation Signs Definitive Distribution Agreement With ASKA Pharmaceutical for Commercialization of SOH-075
11/2/2009 8:47:43 AM
More...
|
Sosei Group Corporation Announces Deal With UK Biotech Company
10/14/2009 8:58:04 AM
More...
|
Sosei Group Corporation Assigns AD 923 Assets to Pharmasol
10/6/2009 7:48:32 AM
More...
|
Sosei Group Corporation Announces Filing of NDA for SOH-075 (NorLevo(R)) in Japan
9/30/2009 9:00:08 AM
More...
|
Sosei Group Corporation: QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
9/16/2009 8:30:15 AM
More...
|
Sosei Group Corporation and Vectura Group plc Announce Start of Phase III Clinical Study With NVA237
6/29/2009 8:29:36 AM
More...
|
Sosei Group Corporation Announces Buyback of the Commercialization Rights to AD 923 from Mundipharma AG
12/29/2008 6:59:33 AM
More...
|
Sosei Group Corporation Confirms the Safety of SD118 in Two Phase I Trials
12/8/2008 8:11:22 AM
More...
|
Sosei Group Corporation Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria
11/26/2008 7:58:33 AM
More...
|
Sosei Group Corporation and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
11/19/2008 11:08:15 AM
More...
|